A reduction of urinary phosphate follows the intravenous infusion of calcium in normal individuals (1-3). The fall in phosphate excretion has been ascribed to an inhibition of parathyroid function by the elevated plasma calcium level (2, 3) .
A reduction of urinary phosphate follows the intravenous infusion of calcium in normal individuals (1) (2) (3) . The fall in phosphate excretion has been ascribed to an inhibition of parathyroid function by the elevated plasma calcium level (2, 3) .
A decrease in renal tubular reabsorption of phosphate following the administration of parathyroid extract has been demonstrated (4) . Therefore, variations in endogenous parathyroid secretion may be expected to result in changes in phosphate reabsorption by the tubule. If the depression of P 8 excretion following the infusion of calcium is the result of an inhibition of parathyroid activity, it should be accompanied by an increase in P reabsorption by the renal tubule. Such a phenomenon was demonstrated in renal function studies carried out during and immediately following calcium infusions. One might anticipate, further, that alterations in the level of circulating parathyroid hormone would affect the usual response of urinary P to calcium administration. Thus, no fall in urinary P was observed by Howard, Hopkins, and Connor in profoundly hypoparathyroid patients given calcium infusions (3) . This observation has been confirmed by our studies. The maintenance of a constant level of circulating parathyroid hormone by the daily administration of a fixed quantity of extract might also be expected to abolish the P response to Ca infusions in normal subjects. This hypothesis, too, was confirmed in the studies to be reported. 2Present address: Department of Physiology, Cornell University Medical College, New York 21, N. Y. 8 As in the previous papers, the following abbreviations have been used: Ca, calcium; P, inorganic phosphorus; Tm, maximum renal tubular rate of transfer.
METHODS
Most of the subjects and methods employed in this study were described in a previous paper (5) . Additional subjects included: R. B., a 22-year-old normal volunteer; T. R., a 70-year-old male with paralysis agitans; E. S., a 7-year-old girl with osteogenesis imperfecta; and V. M., a 40-year-old woman with osteitis deformans and rheumatoid arthritis.
Except where otherwise noted, the studies were carried out with the patients on constant diets containing 130 mg. of Ca and 600 mg. of P. The diets were fed for at least three days before control blood and urine collections were begun. Urine was collected at the intervals indicated and refrigerated until analyses were performed. The completeness of urine collections was checked on all samples by creatinine determinations, carried out according to the method of Bonsnes and Taussky (6) .
Calcium in an amount of 15 mg. per kilogram of body weight was administered intravenously as the gluconate salt, dissolved in 1000 ml. of 0.9 per cent saline over a four-hour period, generally from 8 a.m. to 12 m.
Heparinized venous blood samples for determinations of plasma Ca and P were obtained, one in the fasting state before the infusion was begun, and another at the conclusion of the infusion, before the subject was given lunch, and at least three hours after breakfast. Urine was generally collected in 4, 8, or 12-hour aliquots on one or more days prior to, and on the day following, as well as on the day of the Ca infusion. No ill effects were noted in the patients receiving calcium infusions. The studies of renal function and the administration of parathyroid extract were carried out as described in earlier papers (4, 5) .
RESULTS

Effects of Ca infusions on P excretion in normal subjects
In 33 studies in 9 subjects with normal parathyroid function, a 4-hour infusion containing 15 mg. of Ca per kilogram of body weight led to a fall in the 24-hour urinary P excretion of 9 to 71 per cent. The decrease in urinary P was most pronounced during the 8 to 24 hours following the start of the Ca infusion. In most subjects a rise 573 in P excretion was observed during the 4 hours in which Ca was infused, and in several subjects this increase continued during the four hours following the completion of the Ca infusion (Figure 1 ). Hence the inhibitory effect of the calcium infusion on urinary P was actually greater than was apparent from a measurement of only the total 24-hour P excretion.
Effects of Ca infusions on P excretion in patients with parathyroid disease In the only subject with profound hypoparathyroidism studied the infusion of calcium on four occasions led to a marked rise in P excretion, not only during the Ca infusion, as in normal subjects, but throughout the remainder of the 24-hour period ( Figure 2 ). One subject who had mild, but unequivocal clinical and laboratory manifestations of hypoparathyroidism had a decrease in urinary P excretion following a calcium infusion (Figure 3 ). In this subject no significant change in P excretion was observed upon examination of only the data for the entire 24 have a parathyroid adenoma, had no change in urinary P following a calcium infusion.
Effect of dietary intake on the response of P excretion to Ca infusions All of the studies reported above and many of those described in the literature were carried out with the subjects on constant diets containing small quantities of Ca and P. Changes in the intake of these minerals were shown to have no qualitative influence on the decrease in urinary P which followed Ca infusions (Table I) . In most subjects, however, the fall in urinary P relative to the excretion on the control day was more striking on the low Ca-low P diet than when the intake of Ca or P was increased. Variations in urinary P when the intake of this mineral was inconstant were so great that no conclusions could be drawn concerning the influence of Ca infusions under such conditions. Of interest is the fact that an increase in dietary Ca while the intake of P was held constant led to a sustained fall in urinary P comparable to that seen following the intravenous administration of Ca (Table I, C. H., R. H.). Complete metabolic balance studies indicated that the increase in Ca intake resulted in an increased P storage, rather than a shift of P from urine to the stools. Effect of administration of parathyroid extract on the response of P excretion to Ca infusions The fall in urinary P during calcium infusions in normal subjects and the absence of such a phenomenon in severely hypoparathyroid individuals have led to the postulate that the decrease in P excretion results from a diminution of parathyroid secretion. To test this hypothesis parathyroid extract was administered at several dosage levels to normal subjects. After the completion of one or more control studies, parathyroid extract was given at each dosage level until the 24-hour urinary excretion of P was reasonably constant and continued through the day on which the calcium was infused. It was reasoned that if the decrease in urinary P were the result of an inhibition of parathyroid secretion, a Ca infusion should have no effect on P excretion in a subject receiving a constant amount of exogenous parathyroid extract. Such was found to be the case, the effect of Ca infusions on P excretion becoming progressively less with increasing dosage of parathyroid extract, and finally disappearing when the patient was receiving 300 units of parathyroid extract daily (Figure 4) . (Why the urinary P excretion in the study described in Figure 4 was lower with the subject receiving 300 units of parathyroid extract daily than with 200 units is not known. The same lot of parathyroid was used, and the serum Ca at the 300-unit level was 11.45 mg. per cent, as compared with 10.00 at 200 units.)
A similar phenomenon was observed in 4 other subjects (Table II) . The daily administration of 200 units of parathyroid extract to the subject with severe hypoparathyroidism led to a restoration to normal of the plasma and urinary Ca and P, but had no effect on the profound increase in P excretion observed in this subject in response to Ca infusions.
Effect of Ca infusions on plasma P
The intravenous infusion of Ca led to an increase of up to 50 per cent in the plasma P in al- To investigate further the mechanism of the changes in phosphate excretion resulting from Ca infusions, renal clearance studies were carried out before, during, and after such infusions in normal subjects. Phosphate excretion in one subject was found to be 20 pM per minute prior to, 25 pM per minute during, and 7 uM per minute 16 hours following a calcium infusion (Table  III) . The rise in P excretion during the Ca infusion was found to be the result of an increase in filtered phosphate, which, in turn, was consequent to a rise in plasma phosphate. The reabsorbed phosphate was shown to be increased during the Ca infusion. Sixteen hours following the infusion the filtered phosphate was still considerably higher than the pre-infusion level, again as a result of an increased plasma phosphate (which had not yet returned to its control value). At this time since the tubular reabsorption of P remained high, there was a fall in the excretion of P.
Because the Ca infusions led to a rise in plasma P, the aforementioned studies did not permit an assessment of renal tubular reabsorption under conditions of equal filtered loads of phosphate. Hence, similar studies were carried out, but with the intravenous administration of enough phosphate before and following the Ca infusion to raise the serum phosphate to the level anticipated during the Ca infusion (Table IV, Figure 5 ). In the study of R. H. (Table IV) it is clear that at equivalent loads of filtered P approximately 40 per cent more P was reabsorbed during, and 16 hours following a Ca infusion than during the con-parable filtered P loads, the P excretion is less trol period. The excretion of phosphate during during the Ca infusion than during the control the Ca infusion was increased over the control periods (26 FM per minute as compared with 76).
(26 pM per minute vs. 12). However, at com-Indeed, a rise in P reabsorption occurred during The portion of the intravenously administered calcium retained was considered to be the difference between the amount of calcium administered and the increase in urinary calcium on the day of the calcium infusion over the excretion on the previous day. Since fecal calcium was not measured during these studies, the figure for calcium retention is only approximate; previous work, however, has indicated that only a small proportion of intravenously administered calcium appears in the stool (7). The calcium retention approximated 70 per cent of the administered dose in 4 of subjects without parathyroid disease (Table   V) . In all subjects the fraction of calcium retained was remarkably constant when determined on more than one occasion, even several months apart. The low urinary excretion and high retention of Ca by A. W. was undoubtedly ascribable to the low baseline level of plasma Ca. In this individual, the Ca infusion led to a rise in plasma Ca from approximately 7.0 mg. per cent to 10 mg. per cent. Hence, the filtered load of calcium was undoubtedly lower than that occurring in normal individuals.
DISCUSSION
The decrease in urinary P which follows the intravenous administration of Ca appears to be mediated by the parathyroids. We have confirmed the reports of others (3, 8) that markedly hypoparathyroid subjects respond to Ca infusions with an increase in urinary P. In addition, we have observed the abolition of the usual response to Ca infusions in normal subjects by the administration of parathyroid extract. The amount of extract required to achieve this end was surprisingly large; in one subject P excretion was inhibited by Ca infusions until a daily dosage of 300 units was reached. We had postulated that the response to Ca would disappear upon the administration of an amount of extract approximating the endogenous parathyroid secretion. On the basis of maintenance requirements of patients with hypoparathyroidism, we had estimated this figure to be considerably less than 300 units daily.
Our data support the advice that studies of the influence of Ca on P excretion be done only after at least three days on a diet constant in calcium and phosphorus content, and preferably low in these minerals. All of our subjects, normal, hypoparathyroid, and those with induced hyperparathyroidism, showed a rise in urinary P during the period of Ca infusion. Hence, if this procedure be employed as a measure of parathyroid function, its usefulness would be increased by collecting urine during the period 8 to 24 hours following the start of a four-hour Ca infusion, and during a corresponding period on the control day. Since our subject with mild hypoparathyroidism showed a "normal" response to Ca administration, it is unlikely that this test can be considered a sensitive index of parathyroid insufficiency.
Whether the level of serum Ca governs parathyroid secretion remains unknown. No detectable change in serum level occurred in patients whose dietary Ca was increased, but a profound and sustained fall in P excretion followed. The apparent relationship of serum or dietary Ca to parathyroid secretion does not, of course, preclude the possibility that other factors influence both parathyroid function and phosphate transport by the renal tubule. Indeed, a profound depression of TmP was demonstrated following the intravenous administration of large quantities of P, and this phenomenon was not reversed by the repeated intravenous administration of Ca (9) . The mechanism of the increase in plasma P which follows a rise in serum Ca has not been demonstrated in these studies. It is clear, however, that it is not dependent on the integrity of the parathyroids, and that it is independent of changes in the urinary excretion of P. Evidence that the elevation of serum Ca leads to a shift of P from the cells has been advanced by Chen and Neuman (10) .
Our studies demonstrate that the rise in urinary P seen during a Ca infusion reflects an increase in filtered P, in turn the result of the rise in plasma P. Of interest is the observation that the reabsorbed P reached its maximal level within three hours after the start of the Ca infusion. If the change in tubular transport of P reflects an inhibition of parathyroid secretion, and if the duration of action of the parathyroid hormone already circulating prior to the Ca infusion approximates the six hours found to be the case in the dog by Hastings and Huggins (11), then one might have expected phosphate reabsorption to have been unchanged for several hours. There exists the possibility that during the period of the elevated serum Ca level the rise in reabsorbed P as measured appears to be higher than it actually is, as a result of the presence of a non-filtrable Ca-P complex. This seems unlikely, however, in light of the ultra-filtrability studies of Hopkins, Howard, and Eisenberg (12) , and also because of the close correspondence of the figures for reabsorbed P during the Ca infusions and several hours later when the plasma Ca had returned to normal levels. The increase in tubular reabsorption of P during the Ca infusion recalls a similar phenomenon observed by Foulks following the administration of sulfate to dogs (13) . In both instances the rise in tubular reabsorption was accompanied by an elevation of serum P, and, hence, presumably by a decrease in intracellular P. Foulks postulated that a lowered intracellular P will effect a rise in the quantity of P reabsorbed by the renal tubules (13) .
Schilling and Laszlo (14) have suggested that the avidity of the skeleton for calcium can be estimated from the proportion of an intravenously administered dose of Ca not appearing in the urine.
They have found that normal subjects retain approximately 70 per cent of the Ca infused, while cancer patients with osteolytic processes retain less, and those with osteoblastic metastases retain more. The behaviour of most of our normal subjects corresponded closely to that reported by Schilling and Laszlo, and the response of those subjects tested on' more than one occasion showed little variation. The consistently high excretion of the administered Ca by one young normal control subject without evidence of parathyroid or bone disease, however, suggests that this test can--not by itself be used as an index of the presence of bone disease. SUMMARY 1. The intravenous administration of calcium gluconate to normal subj ects results in a diminution in the urinary excretion of phosphorus. This phenomenon occurs as a result of increased renal tubular reabsorption of phosphate.
2. This effect of administered calcium appears to require normally functioning parathyroid glands, since it is not seen in patients with profound hypoparathyroidism or hyperparathyroidism, and it can be abolished in normal subjects by the prior administration of parathyroid extract.
3. No change, or even an elevation in P excretion occurs during the administration of calcium. Hence, more striking reductions in P excretion are detected if urine is collected during the 8 to 24 hours after the four-hour infusion of calcium is begun, and compared with the corresponding period on the control day.
4. The response of urinary P excretion to calcium administration is not a sensitive test for hypoparathyroidism, since patients with clinically apparent, but mild hypoparathyroidism may show a pattern similar to that of normal subjects.
5. The percentage of administered calcium retained by a given individual is quite constant on repeated testing. However, unexplained variability occurs in the amount retained by different subjects.
6. The intravenous infusion of calcium leads to a prompt rise in plasma phosphate in almost all subjects. The rise occurs before there is any reduction in urinary excretion of P, and hence must represent mobilization from intracellular stores. In some individuals large doses of parathyroid extract abolish this elevation of plasma P.
